• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development and validation of the appearance and performance enhancing drug use schedule.外表和表现增强药物使用时间表的制定和验证。
Addict Behav. 2011 Oct;36(10):949-58. doi: 10.1016/j.addbeh.2011.05.002. Epub 2011 May 11.
2
Fitness supplements as a gateway substance for anabolic-androgenic steroid use.健身补充剂作为合成代谢雄激素类固醇使用的入门物质。
Psychol Addict Behav. 2012 Dec;26(4):955-62. doi: 10.1037/a0027877. Epub 2012 Apr 9.
3
The diagnostic dilemma of pathological appearance and performance enhancing drug use.病理性表现和使用兴奋剂的诊断困境。
Drug Alcohol Depend. 2011 Mar 1;114(1):1-11. doi: 10.1016/j.drugalcdep.2010.09.018. Epub 2010 Nov 5.
4
Psychosocial correlates of gap time to anabolic-androgenic steroid use.使用合成代谢雄激素类固醇的时间间隔的心理社会相关因素。
Int J Eat Disord. 2018 Jun;51(6):535-541. doi: 10.1002/eat.22859. Epub 2018 Mar 15.
5
Modeling population heterogeneity in appearance- and performance-enhancing drug (APED) use: applications of mixture modeling in 400 regular APED users.塑造使用外观和性能增强药物(APED)人群的异质性:混合模型在400名常规APED使用者中的应用
J Abnorm Psychol. 2007 Nov;116(4):717-33. doi: 10.1037/0021-843X.116.4.717.
6
Psychological and physical impact of anabolic-androgenic steroid dependence.合成代谢类固醇依赖的心理和生理影响。
Pharmacotherapy. 2012 Oct;32(10):910-9. doi: 10.1002/j.1875-9114.2012.01123.
7
Body image disturbance in 1000 male appearance and performance enhancing drug users.1000 名男性容貌和运动表现增强药物使用者的身体意象障碍。
J Psychiatr Res. 2010 Oct;44(13):841-6. doi: 10.1016/j.jpsychires.2010.01.001. Epub 2010 Jan 27.
8
Cross-cultural validation of the Clinician-Administered PTSD scale for DSM-5, child and adolescent version in Japan.跨文化验证 DSM-5 儿童和青少年版临床医生管理创伤后应激障碍量表在日本的适用性。
Eur J Psychotraumatol. 2024;15(1):2424607. doi: 10.1080/20008066.2024.2424607. Epub 2024 Nov 15.
9
A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity.一种用于诊断合成代谢雄激素类固醇依赖的访谈模块:可靠性和有效性的初步证据。
Exp Clin Psychopharmacol. 2010 Jun;18(3):203-13. doi: 10.1037/a0019370.
10
Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA).使用药物依赖和酒精中毒半结构化评估(SSADDA)的《精神疾病诊断与统计手册》第四版(DSM-IV)诊断标准的可靠性
Drug Alcohol Depend. 2007 Nov 2;91(1):85-90. doi: 10.1016/j.drugalcdep.2007.04.014. Epub 2007 Jun 27.

引用本文的文献

1
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study.男性使用合成代谢雄激素类固醇的健康服务参与度、副作用和担忧:一项挪威的横断面研究。
Subst Abuse Treat Prev Policy. 2023 Apr 3;18(1):19. doi: 10.1186/s13011-023-00528-z.
2
Appearance and performance-enhancing drugs and supplements, eating disorders, and muscle dysmorphia among gender minority people.跨性别者中的外貌和性能增强药物和补充剂、饮食失调和肌肉变形。
Int J Eat Disord. 2022 May;55(5):678-687. doi: 10.1002/eat.23708. Epub 2022 Mar 30.
3
Appearance and performance-enhancing drugs and supplements (APEDS): Lifetime use and associations with eating disorder and muscle dysmorphia symptoms among cisgender sexual minority people.外观和性能增强药物和补充剂 (APEDS):跨性别性少数群体人群中的终身使用与饮食障碍和肌肉变形症症状的关联。
Eat Behav. 2022 Jan;44:101595. doi: 10.1016/j.eatbeh.2022.101595. Epub 2022 Jan 12.
4
Conformity to masculine norms and symptom severity among men diagnosed with muscle dysmorphia vs. body dysmorphic disorder.男性肌肉变形症与躯体变形障碍患者遵从男性规范与症状严重程度的关系。
PLoS One. 2020 Aug 20;15(8):e0237651. doi: 10.1371/journal.pone.0237651. eCollection 2020.
5
Female Body Dissatisfaction and Attentional Bias to Body Images Evaluated Using Visual Search.使用视觉搜索评估女性对身体形象的不满及注意偏向
Front Psychol. 2020 Jan 22;10:2821. doi: 10.3389/fpsyg.2019.02821. eCollection 2019.
6
Anabolic androgenic steroid abuse in the United Kingdom: An update.英国的合成代谢雄激素类固醇滥用:最新进展。
Br J Pharmacol. 2020 May;177(10):2180-2198. doi: 10.1111/bph.14995. Epub 2020 Mar 3.
7
The association between muscle dysmorphia and eating disorder symptomatology: A systematic review and meta-analysis.肌肉变形障碍与饮食障碍症状的关联:系统评价和荟萃分析。
J Behav Addict. 2019 Sep 1;8(3):351-371. doi: 10.1556/2006.8.2019.44. Epub 2019 Sep 11.
8
Defining the Construct of Synthetic Androgen Intoxication: An Application of General Brain Arousal.定义合成雄激素中毒的概念:一般脑觉醒的应用。
Front Psychol. 2018 Mar 29;9:390. doi: 10.3389/fpsyg.2018.00390. eCollection 2018.
9
Understanding Appearance-Enhancing Drug Use in Sport Using an Enactive Approach to Body Image.运用具身认知方法理解体育界使用外观增强药物的现象与身体意象的关系。
Front Psychol. 2017 Nov 29;8:2088. doi: 10.3389/fpsyg.2017.02088. eCollection 2017.
10
The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men.发病年龄和急性合成代谢类固醇暴露对男性认知能力、冲动性及攻击性的影响。
Psychol Addict Behav. 2014 Dec;28(4):1096-104. doi: 10.1037/a0036482. Epub 2014 May 19.

本文引用的文献

1
The diagnostic dilemma of pathological appearance and performance enhancing drug use.病理性表现和使用兴奋剂的诊断困境。
Drug Alcohol Depend. 2011 Mar 1;114(1):1-11. doi: 10.1016/j.drugalcdep.2010.09.018. Epub 2010 Nov 5.
2
Substance abusers' motives for using anabolic androgenic steroids.滥用物质者使用合成代谢雄激素类固醇的动机。
Drug Alcohol Depend. 2010 Sep 1;111(1-2):170-2. doi: 10.1016/j.drugalcdep.2010.04.008. Epub 2010 May 21.
3
Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction.长期使用合成代谢雄激素类固醇与左心室功能障碍有关。
Circ Heart Fail. 2010 Jul;3(4):472-6. doi: 10.1161/CIRCHEARTFAILURE.109.931063. Epub 2010 Apr 27.
4
Dopaminergic dysregulation in mice selectively bred for excessive exercise or obesity.过度运动或肥胖的小鼠中多巴胺能的失调。
Behav Brain Res. 2010 Jul 11;210(2):155-63. doi: 10.1016/j.bbr.2010.02.016. Epub 2010 Feb 13.
5
Growth hormone administration: is it safe and effective for athletic performance.生长激素治疗:对运动表现安全且有效吗。
Endocrinol Metab Clin North Am. 2010 Mar;39(1):11-23, vii. doi: 10.1016/j.ecl.2009.10.007.
6
Body image disturbance in 1000 male appearance and performance enhancing drug users.1000 名男性容貌和运动表现增强药物使用者的身体意象障碍。
J Psychiatr Res. 2010 Oct;44(13):841-6. doi: 10.1016/j.jpsychires.2010.01.001. Epub 2010 Jan 27.
7
Designer steroids.设计类固醇
Handb Exp Pharmacol. 2010(195):155-85. doi: 10.1007/978-3-540-79088-4_7.
8
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review.从动物模型到内表型探索强迫和冲动行为:叙述性综述。
Neuropsychopharmacology. 2010 Feb;35(3):591-604. doi: 10.1038/npp.2009.185. Epub 2009 Nov 25.
9
Anabolic-androgenic steroid dependence: an emerging disorder.合成代谢雄激素类固醇依赖:一种新兴障碍。
Addiction. 2009 Dec;104(12):1966-78. doi: 10.1111/j.1360-0443.2009.02734.x.
10
Illicit anabolic-androgenic steroid use.非法使用 anabolic-androgenic 类固醇。
Horm Behav. 2010 Jun;58(1):111-21. doi: 10.1016/j.yhbeh.2009.09.006. Epub 2009 Sep 18.

外表和表现增强药物使用时间表的制定和验证。

Development and validation of the appearance and performance enhancing drug use schedule.

机构信息

Eating and Weight Disorders Program, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1230, New York, NY 10029, USA.

出版信息

Addict Behav. 2011 Oct;36(10):949-58. doi: 10.1016/j.addbeh.2011.05.002. Epub 2011 May 11.

DOI:10.1016/j.addbeh.2011.05.002
PMID:21640487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3159027/
Abstract

Appearance-and-performance enhancing drug (APED) use is a form of drug use that includes use of a wide range of substances such as anabolic-androgenic steroids (AASs) and associated behaviors including intense exercise and dietary control. To date, there are no reliable or valid measures of the core features of APED use. The present study describes the development and psychometric evaluation of the Appearance and Performance Enhancing Drug Use Schedule (APEDUS) which is a semi-structured interview designed to assess the spectrum of drug use and related features of APED use. Eighty-five current APED using men and women (having used an illicit APED in the past year and planning to use an illicit APED in the future) completed the APEDUS and measures of convergent and divergent validity. Inter-rater agreement, scale reliability, one-week test-retest reliability, convergent and divergent validity, and construct validity were evaluated for each of the APEDUS scales. The APEDUS is a modular interview with 10 sections designed to assess the core drug and non-drug phenomena associated with APED use. All scales and individual items demonstrated high inter-rater agreement and reliability. Individual scales significantly correlated with convergent measures (DSM-IV diagnoses, aggression, impulsivity, eating disorder pathology) and were uncorrelated with a measure of social desirability. APEDUS subscale scores were also accurate measures of AAS dependence. The APEDUS is a reliable and valid measure of APED phenomena and an accurate measure of the core pathology associated with APED use. Issues with assessing APED use are considered and future research is considered.

摘要

外观和表现增强药物(APED)的使用是一种药物使用形式,包括使用广泛的物质,如合成代谢雄激素类固醇(AAS)和相关行为,包括剧烈运动和饮食控制。迄今为止,还没有可靠或有效的方法来衡量 APED 使用的核心特征。本研究描述了外观和表现增强药物使用时间表(APEDUS)的开发和心理测量评估,这是一种半结构化访谈,旨在评估药物使用的范围和 APED 使用的相关特征。85 名目前正在使用 APED 的男性和女性(过去一年中使用过非法 APED,并计划在未来使用非法 APED)完成了 APEDUS 以及聚合和发散有效性的测量。评估了 APEDUS 每个量表的评分者间一致性、量表可靠性、一周重测信度、聚合和发散有效性以及结构有效性。APEDUS 是一个具有 10 个部分的模块化访谈,旨在评估与 APED 使用相关的核心药物和非药物现象。所有量表和个别项目都表现出较高的评分者间一致性和可靠性。个别量表与聚合性测量(DSM-IV 诊断、攻击性、冲动性、饮食障碍病理)显著相关,与社会期望测量无关。APEDUS 子量表得分也是 AAS 依赖的准确衡量标准。APEDUS 是一种可靠和有效的 APED 现象衡量标准,也是 APED 使用相关核心病理的准确衡量标准。考虑到评估 APED 使用的问题,并考虑了未来的研究。